Literature DB >> 11126535

Effects of initial dose on eastern equine encephalomyelitis virus dependent mortality in intrathoracically inoculated Culiseta melanura (Diptera: Culicidae).

L A Cooper1, B J Sina, M J Turell, T W Scott.   

Abstract

Viral growth characteristics that favor rapid and prodigious virion production may increase virus transmission but be detrimental to infected hosts. Several arboviruses, including eastern equine encephalomyelitis (EEE) virus, negatively affect the survival of their infected mosquito vectors. To test the hypothesis that the mosquito virulent properties of EEE virus are caused by the presence of intrinsic viral growth properties, we investigated the effects of infecting dose on the survival of intrathoracically inoculated Culiseta melanura (Coquillett). Daily survival of age-matched females inoculated with either a low initial dose of 10(1.5) plaque-forming units (PFUs) per mosquito or a high initial dose of 10(5.5) PFUs per mosquito was monitored for 8 wk. Compared with diluent inoculated controls, mosquitoes from both dosage groups displayed highly significant decreases in survival. No significant differences in daily survival were detected between the two infected groups. Virus production within inoculated mosquitoes was assessed by sampling mosquitoes every 12 h for 96 h after inoculation. Rapid virus amplification occurred in both dosage groups, and by 24 h after exposure the mean viral loads in mosquitoes inoculated with the low dose were comparable to those inoculated with the high dose. Likewise, although detectable virions appeared sooner in the saliva of high dosage mosquitoes, by 72 h after inoculation no significant differences in virus transmission were detected between the two exposure groups. These results indicate that the virulence of EEE virus for its enzootic North American mosquito vector is not dosage dependent and likely reflects the inherent growth properties of this virus within infected mosquitoes.

Entities:  

Mesh:

Year:  2000        PMID: 11126535     DOI: 10.1603/0022-2585-37.6.815

Source DB:  PubMed          Journal:  J Med Entomol        ISSN: 0022-2585            Impact factor:   2.278


  8 in total

1.  Vector Competence and Capacity of Culex erraticus (Diptera: Culicidae) for Eastern Equine Encephalitis Virus in the Southeastern United States.

Authors:  Andrea M Bingham; Nathan D Burkett-Cadena; Hassan K Hassan; Thomas R Unnasch
Journal:  J Med Entomol       Date:  2016-03       Impact factor: 2.278

2.  Differential mortality of dog tick vectors due to infection by diverse Francisella tularensis tularensis genotypes.

Authors:  Heidi K Goethert; Sam R Telford
Journal:  Vector Borne Zoonotic Dis       Date:  2011-05-25       Impact factor: 2.133

3.  Differential evolution of eastern equine encephalitis virus populations in response to host cell type.

Authors:  L A Cooper; T W Scott
Journal:  Genetics       Date:  2001-04       Impact factor: 4.562

4.  Vector competence of Culex (Melanoconion) taeniopus for equine-virulent subtype IE strains of Venezuelan equine encephalitis virus.

Authors:  Eleanor R Deardorff; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

5.  Mode of transmission and the evolution of arbovirus virulence in mosquito vectors.

Authors:  Louis Lambrechts; Thomas W Scott
Journal:  Proc Biol Sci       Date:  2009-01-13       Impact factor: 5.349

6.  The RNA interference pathway affects midgut infection- and escape barriers for Sindbis virus in Aedes aegypti.

Authors:  Cynthia C H Khoo; Joseph Piper; Irma Sanchez-Vargas; Ken E Olson; Alexander W E Franz
Journal:  BMC Microbiol       Date:  2010-04-28       Impact factor: 3.605

7.  Effects of inducing or inhibiting apoptosis on Sindbis virus replication in mosquito cells.

Authors:  Hua Wang; Carol D Blair; Ken E Olson; Rollie J Clem
Journal:  J Gen Virol       Date:  2008-11       Impact factor: 3.891

8.  Combination of Cetuximab and Oncolytic Virus Canerpaturev Synergistically Inhibits Human Colorectal Cancer Growth.

Authors:  Zhiwen Wu; Toru Ichinose; Yoshinori Naoe; Shigeru Matsumura; Itzel Bustos Villalobos; Ibrahim Ragab Eissa; Suguru Yamada; Noriyuki Miyajima; Daishi Morimoto; Nobuaki Mukoyama; Yoko Nishikawa; Yusuke Koide; Yasuhiro Kodera; Maki Tanaka; Hideki Kasuya
Journal:  Mol Ther Oncolytics       Date:  2019-05-13       Impact factor: 7.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.